Trial · NCT01594749
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Complete Response From 25 to 120 Hours After Initiation of Moderately Emetogenic Chemotherapy (MEC) | Fosaprepitant Regimen | 78.9 | Percentage of Participants | ||
| Percentage of Participants With Complete Response From 25 to 120 Hours After Initiation of Moderately Emetogenic Chemotherapy (MEC) | Control Regimen | 68.5 | Percentage of Participants | ||
| Percentage of Participants With Infusion-site Thrombophlebitis | Fosaprepitant Regimen | 0.6 | Percentage of Participants | ||
| Percentage of Participants With Infusion-site Thrombophlebitis | Control Regimen | 0.0 | Percentage of Participants | ||
| Percentage of Participants With Severe Infusion-site Reactions | Fosaprepitant Regimen | 0.0 | Percentage of Participants | ||
| Percentage of Participants With Severe Infusion-site Reactions | Control Regimen | 0.0 | Percentage of Participants | ||
| Percentage of Participants With Complete Response From 0 to 120 Hours After Initiation of MEC | Fosaprepitant Regimen | 77.1 | Percentage of Participants | ||
| Percentage of Participants With Complete Response From 0 to 120 Hours After Initiation of MEC | Control Regimen | 66.9 | Percentage of Participants | ||
| Percentage of Participants With Complete Response From 0 to 24 Hours After Initiation of MEC | Fosaprepitant Regimen | 93.2 | Percentage of Participants | ||
| Percentage of Participants With Complete Response From 0 to 24 Hours After Initiation of MEC | Control Regimen | 91.0 | Percentage of Participants | ||
| Percentage of Participants With No Vomiting From 0 to 120 Hours After Initiation of MEC | Fosaprepitant Regimen | 82.7 | Percentage of participants | ||
| Percentage of Participants With No Vomiting From 0 to 120 Hours After Initiation of MEC | Control Regimen | 72.9 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01594749/results